GlobeNewsWire · SNY · November 18, 2026
Press Release: Sanofi's Infilbray approved in the US as the first medicine to treat neurological manifestations of Type 3 Gaucher disease

Get the app for more
Explore stock news, insights and company research.
Get the app → Source: GlobeNewsWire ↗